Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 340

A simple method compares hybrids with term deposits

The extra return paid to investors for taking risk has been heavily influenced by the reach for yield. It affects many spread margins (or excess returns) such as on high-yielding corporate bonds and (even) ordinary equity.

With cash and bond rates set to remain ‘lower for longer’, the transfer mechanism from 'risk free' with almost zero return to 'risk on' becomes self-fulfilling. This is the situation that Australia now finds itself in. Low interest rates, predicted by the 10-year bond rate to remain so for an extended period, assist with benign corporate and household default conditions.

Breakeven analysis: term deposit versus hybrid

As the reach for yield intensifies, do investors know if the return on invested capital at risk is sufficient compensation versus the risk-free rate to justify the investment? This is the question investors should always ask themselves before making any investment.

There is no right or wrong answer because individual investor risk tolerances vary. For example, we might assess hybrid capital instruments to have little risk at present arguing that the improved credit health of the issuers justifies pricing closer to more senior instruments of the same issuer. However, other investors will rank them only marginally ahead of ordinary equity perceiving them to be highly risky.

We use a number of methods to assess the risks inherent in individual securities and in aggregate terms, in our portfolios. One method, breakeven analysis, provides us with a relatively simple method of assessing whether the excess return over a prescribed benchmark index or even the risk-free rate provides sufficient compensation for the additional risk. It helps to compare assets of differing seniority, term and credit quality.

Using an example of a major Australian bank term deposit returning approximately 1% on an annual basis and the PERLS VII hybrid capital instrument (ASX:CBAPD), currently yielding approximately 3.5% per annum, puts the excess return in perspective.

Assume $100 is invested in a term deposit for 2 years (a reasonable time frame) at 1% per annum. Ignoring compound interest, investors earn $2 or 2% over the 2-year period.

Now, investing in CBAPD, we can assume the floating benchmark reference rate will be 1% (i.e. BBSW), the return over the same period, including the value of franking, will be 3.5% in year 1 followed by 3.5% in year 2, a total of $7 or 7%.

While the return is 3.5 times the risk-free term deposit rate, the investment is in a ‘risk’ asset where there is some probability, albeit a very low, of a capital loss over the period. Using breakeven analysis, it is possible to make a value judgement on the return versus the risk.

Making sense of the numbers

Let’s assume there is an ‘event’ and the capital value of the hybrid CBAPD declines. The question you should ask is:

How far does the capital value of CBAPD have to fall by the end of the period (i.e 2 years) before an investor would have been better off investing in the term deposit?

The capital loss on CBAPD would have to be greater than $5 (i.e the difference between earnings on CBAPD and the term deposit) before you would have been better off in the term deposit.

That is, if you buy CBAPD at $100 today you could sell it for $95 at the end of the period (year 2) and be no worse off than investing in the term deposit at 1% p.a. for 2 years. The table below summarises this information.

 

Income (annual rate)

Return @ end 2 years

Amount Invested

Income earned on $100 over 2 years

At end year 2 ($100 + income)

Breakeven CBAPD price @ end year 2 to = 2-year TD income

2-year TD

1%

2%

$100

$2

$102

n/a

CBAPD

3.50%

7%

$100

$7

$107

$95

What does this tell us?

The interesting fact is that at a price of $95 in 2 years’ time (in January 2022), the yield-to-maturity to the first call in December 2022 of CBAPD would approximate to 9% per annum. That is, the change in capital value plus the  coupon and franking. At 9%, the spread margin represents an excess margin of 800 basis points or 8% over the risk-free rate which would be amazing value, everything being equal, for an asset of that credit quality (CBA risk) and term (one year).

While CBAPD has traded at a price below $95 in its life since its 2014 issuance, as shown below, it was only for a 12-month period in 2015 and 2016 when the term to maturity (first call) was in excess of five years. Since then it has traded at a price in excess of $95 and more recently above $100 (the security’s par value) reflecting a rerating of the risks associated with major bank hybrids and a shortening term to maturity or first call specific to the CBAPD security.

CBAPD Price Daily October 2014 to December 15, 2019

… but diversification is still key

While our portfolios are of similar term and similar average weighted credit quality to the example above, the important difference is that our portfolios contain 35 securities spread across a range of sectors and sub sectors, including banking, insurance, building and construction and infrastructure. The risks associated with investing in a single individual security are significantly reduced. Even with a credit of the quality of CBA, it's worth spreading the risk to other quality names. It is also possible that CBA will not call the hybrid at its first call date, although banks are reluctant to do this as it affects their subsequent visits to the market.

 

Norman Derham is Executive Director of Elstree Investment Management, a boutique fixed income fund manager. This article is general information and does not consider the circumstances of any individual investor.

 

RELATED ARTICLES

The dramatic tale of two hybrids, CBA VII versus VIII

Should you buy CBA PERLS XII Capital Notes?

Why bank hybrids are far too expensive

banner

Most viewed in recent weeks

Check eligibility for the Commonwealth Seniors Health Card

Eligibility for the Commonwealth Seniors Health Card has no asset test and a relatively high income test. It's worth checking eligibility and the benefits of qualifying to save on the cost of medications.

Start the year right with the 2022 Retiree Checklist

This is our annual checklist of what retirees need to be aware of in 2022. It is a long list of 25 items and not everything will apply to your situation. Run your eye over the benefits and entitlements.

At 98-years-old, Charlie Munger still delivers the one-liners

The Warren Buffett/Charlie Munger partnership is the stuff of legends, but even Charlie admits it is coming to an end ("I'm nearly dead"). He is one of the few people in investing prepared to say what he thinks.

Should I pay off the mortgage or top up my superannuation?

Depending on personal circumstances, it may be time to rethink the bias to paying down housing debt over wealth accumulation in super. Do the sums and ask these four questions to plan for your future.

Part 2: Hamish Douglass on not swinging for the fences

Markets don't seem normal, but Magellan is criticised for its caution. Higher interest rates to control inflation could create a recession and some of today's investing will turn out a mass delusion of modern history.

Will 2022 be the year for quality companies?

It is easy to feel like an investing genius over the last 10 years, with most asset classes making wonderful gains. But if there's a setback, companies like Reece, ARB, Cochlear, REA Group and CSL will recover best.

Latest Updates

Investment strategies

Despite the focus on ETFs, unlisted funds still dominate

ETFs gain the headlines as issuers are skilled at promoting their growth and new funds. Yet ETFs are tiny compared with managed funds, which advisers prefer on platforms. Which will be the long-term winner?

Latest from Morningstar

10 lessons from Larry Fink's 2022 Outlook

At a 2022 Outlook event, the influential BlackRock (largest fund manager in the world) CEO spoke about consumer behaviour and its impact on prices, the pandemic, ESG trends and likely equity returns for 2022.

Strategy

If rising inequality leads to social unrest, we all suffer

Feeling financially stressed? The entry level for the world's richest 1% is $1.5 million including the family home. If this is not enough to fund a ‘comfortable’ lifestyle, consider that 99% of people have less.

Shares

Sharemarket falls: seven things for investors to consider

Stockmarkets have fallen in recent weeks on the back of worries about inflation, monetary tightening, Omicron disruption and the risk of a Russian invasion of Ukraine. It’s too early to say markets have bottomed.

Retirement

The importance of retirement 'conditions of release'

Retirement 'conditions of release' vary by age in stages before 60, over 60 and over 65. Super tax benefits may accrue if gainful employment ceases after age 60 but a person may still return to the workforce.

Investment strategies

We need to limit retail investor harm from CFDs

A Contract for Difference (CFD) is a highly-leveraged investment used for speculative and gambling activities by retail investors without the knowledge to take such risks. ASIC is struggling to control the product.

Superannuation

It's time to assess your super fund’s carbon footprint

We face a huge economic transformation that is not a priority for politicians. Yet a typical super portfolio emits about 28 tonnes of CO2 per annum through its equities ownership, more than the average household.

Sponsors

Alliances

© 2022 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.